![]() |
|
|
Vol. 289, Issue 2, 1075-1083, May 1999
Department of Veterinary and Comparative Anatomy, Physiology and
Pharmacology, Washington State University, Pullman, Washington
The angiotensin IV receptor (AT4) receptor is widely
distributed in both species and tissues. This broad distribution
appears to be reflected in an equally diverse repertoire of
physiological actions that are mediated through AT4
receptors. This breadth of location and function of AT4
receptors encourages speculation that multiple AT4 isoforms
might exist. In this study, we compared the structural properties of
bovine AT4 receptors from adrenals, kidney, heart, thymus,
bladder, aorta, and hippocampus. These comparisons were made using
polyacrylamide gel electrophoresis or HPLC analysis of AT4
receptors that had been covalently radiolabeled with the
AT4-specific photoprobe 125I-benzoyl
phenylalamine-angiotensin IV. Except for the hippocampal AT4 receptor, the binding subunit in all tissues had a
molecular mass of approximately 165 kDa and associated with
additional subunits via disulfide linkages. The hippocampal receptor
was significantly smaller (150 kDa) and did not appear to possess other
disulfide-linked subunits. The receptor was highly glycosylated in all
tissues examined. Peptide mapping following cleavage of
125I-labeled receptor with endopeptidase C or cyanogen
bromide resulted in complex cleavage patterns. Together these
mapping studies demonstrated the uniqueness of the hippocampal receptor
and further suggested that other AT4 isoforms may exist and
be variably distributed among bovine tissues. In agreement with the
peptide mapping studies, differences in the binding pattern of several
AngIV analogs were observed among the various tissues.
This article has been cited by other articles:
![]() |
P. R Gard, P. Daw, Z. Sayyad Mashhour, and P. Tran Interactions of angiotensin IV and oxytocin on behaviour in mice Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 133 - 138. [Abstract] [PDF] |
||||
![]() |
J. Lee, T. Mustafa, S. G. McDowall, F. A. O. Mendelsohn, M. Brennan, R. A. Lew, A. L. Albiston, and S. Y. Chai Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 205 - 211. [Abstract] [Full Text] |
||||
![]() |
G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont, and P. Vanderheyden Cellular targets for angiotensin II fragments: pharmacological and molecular evidence Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 195 - 204. [Abstract] [PDF] |
||||
![]() |
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn Bioactive angiotensin peptides: focus on angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210. [PDF] |
||||
![]() |
R. K. HANDA Characterization and Signaling of the AT4 Receptor in Human Proximal Tubule Epithelial (HK-2) Cells J. Am. Soc. Nephrol., March 1, 2001; 12(3): 440 - 449. [Abstract] [Full Text] |
||||
![]() |
S. Ito and A. F. Sved Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2961 - H2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Handa, J. W. Harding, and S. M. Simasko Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1242 - 1249. [Abstract] [Full Text] |
||||